MiR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting <em>HOXA1</em>

Abstract

Together, these results indicated that miR-99a could inhibit NPC invasion and metastasis by targeting <i>HOXA1</i>, thus providing a novel potential target for miRNA-based treatment for NPC patients in the future.